Phacilitate Leaders World

Conference speakers

Loading
Damien Hallet

Damien Hallet

Director, CMC Technical Operations, Precision Biosciences

Damien is part of the Cell Therapy team at Precision BioSciences. He joined Precision from Heat Biologics where he served as the Vice President of Chemistry Manufacturing and Controls and was responsible for the development and manufacturing of allogeneic whole cell cancer vaccines and co-stimulator molecules (antibodies and fusion proteins). Prior to Heat Biologics, Damien was employed at UCB Pharma/Celltech, Sanofi, and Centelion, a subsidiary of Aventis Pharma dedicated to Gene Therapy. Damien received a biochemical engineering degree from INSA de Toulouse, Grande Ecole and earned a Masters of Advanced Studies in Industrial Microbiology from Ecole Doctorale de Toulouse, France. He has developed an expertise with the Chemistry, Manufacturing and Controls of many types of biologic medical products (cell therapy products, monoclonal antibodies, pegylated Fabs, gene therapy adenoviral and plasmid DNA vectors) and is excited to develop and translate this experience to CAR T-cells. When Damien is not trying to troubleshoot manufacturing processes and figure out faster and smarter program development pathways, he can be found messing around with jazz tunes on the piano, taking abstract photography (including his kids and dog!) and running up and down the hills of Chapel Hill.

 

Sessions
Testimonials
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Anne-Virginie Eggimann
    bluebird bio
  • Great program, great people, great venue.
    Klaus Kühlcke
    EUFETS GmbH
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.
    Nathalie Clement
    Powell Gene Therapy Center, University of Florida
  • Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field.
    Dr James Trager
    Dendreon
  • It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives.
    Kurt Gielen
    Chemelot Campus B.V.
  • Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.
    Steven Goodman
    GSK